Beta-thalassemia epidemiology and demographics

Jump to navigation Jump to search

Beta-thalassemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Differentiating Beta-thalassemia from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Beta-thalassemia epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Beta-thalassemia epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Beta-thalassemia epidemiology and demographics

CDC on Beta-thalassemia epidemiology and demographics

Beta-thalassemia epidemiology and demographics in the news

Blogs on Beta-thalassemia epidemiology and demographics

Directions to Hospitals Treating Beta-thalassemia

Risk calculators and risk factors for Beta-thalassemia epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Maryam Hadipour, M.D.[2]

Overview

Epidemiology and Demographics

Prevalence

There are insufficient data about the exact prevalence of beta-thalassemia.

  • The prevalence of beta-thalassemia carrier is 1.5% of the world population.[1]

Incident

  • Recent studies suggest that around 23000 infants with beta-thalassemia major are born every year.[1]

References

  1. 1.0 1.1 De Sanctis V, Kattamis C, Canatan D, Soliman AT, Elsedfy H, Karimi M; et al. (2017). "β-Thalassemia Distribution in the Old World: an Ancient Disease Seen from a Historical Standpoint". Mediterr J Hematol Infect Dis. 9 (1): e2017018. doi:10.4084/MJHID.2017.018. PMC 5333734. PMID 28293406.


Template:WikiDoc Sources